The market share for CRO in Asia Pacific from pharmaceutical & biopharmaceutical companies is set to exceed USD 8,992.3 million by 2028, driven by the higher burden of various chronic diseases, including cancer, cardiac, neurological, infectious and kidney disorders. Read More